Daniela Barila
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
From metabolism to genome integrity: NRF2 as a key mediator of cancer therapy response.
Journal: Frontiers in cell and developmental biology
Published: April 29, 2026
Targeting of a novel interplay between MET tyrosine kinase and NRF2 enhances sensitivity to Paclitaxel in triple negative breast cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 05, 2025
ATM kinase phosphorylates HSP90 on T297 changing its conformation dynamics and promoting its interaction with HER2 receptor tyrosine kinase.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 15, 2025
Caspase-8 expression and its Src dependent phosphorylation on Tyrosine 380 triggers NRF2 signaling activation in glioblastoma.
Journal: Cell death and differentiation
Published: October 10, 2024
NRF2 connects Src tyrosine kinase to ferroptosis resistance in glioblastoma.
Journal: Life science alliance
Published: June 07, 2023
Identification and Biological Characterization of the Pyrazolo[3,4-d]pyrimidine Derivative SI388 Active as Src Inhibitor.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 26, 2023
Caspase-8 and Tyrosine Kinases: A Dangerous Liaison in Cancer.
Journal: Cancers
Published: May 26, 2023
A Triphenylphosphonium-Functionalized Delivery System for an ATM Kinase Inhibitor That Ameliorates Doxorubicin Resistance in Breast Carcinoma Mammospheres.
Journal: Cancers
Published: November 21, 2022
Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy.
Journal: Cell death and differentiation
Published: February 07, 2022
Last Updated: 09/26/2026